PETQ Stock Overview
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
PetIQ, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$16.03 |
| 52 Week High | US$22.98 |
| 52 Week Low | US$11.26 |
| Beta | 1.67 |
| 1 Month Change | -6.86% |
| 3 Month Change | -11.44% |
| 1 Year Change | 36.08% |
| 3 Year Change | -61.97% |
| 5 Year Change | -48.12% |
| Change since IPO | -31.26% |
Recent News & Updates
Recent updates
PetIQ (NASDAQ:PETQ) Seems To Use Debt Quite Sensibly
Apr 13
PetIQ: Cost Savings, Higher EBITDA Suggest A Potential Valuation Re-Rate
Feb 06Investors Will Want PetIQ's (NASDAQ:PETQ) Growth In ROCE To Persist
Sep 15PetIQ, Inc. (NASDAQ:PETQ) Stock Rockets 26% But Many Are Still Ignoring The Company
Aug 16PetIQ (NASDAQ:PETQ) Has A Somewhat Strained Balance Sheet
Aug 10PetIQ's (NASDAQ:PETQ) Returns On Capital Are Heading Higher
Jun 14PetIQ (NASDAQ:PETQ) May Have Issues Allocating Its Capital
Feb 11PetIQ gains 1.84 % on $30M stock repurchase program
Sep 06PetIQ (NASDAQ:PETQ) Use Of Debt Could Be Considered Risky
Aug 23Here's What's Concerning About PetIQ's (NASDAQ:PETQ) Returns On Capital
Jul 27Is PetIQ (NASDAQ:PETQ) Using Too Much Debt?
May 06There Are Reasons To Feel Uneasy About PetIQ's (NASDAQ:PETQ) Returns On Capital
Apr 02The Prognosis For PetIQ
Feb 12PetIQ: Economies Of Scale Will Kick In Eventually
Jan 03PetIQ, Trupanion: Pet Care Industry Small Players Still Not Cheap Enough
Sep 09Why We Think PetIQ, Inc.'s (NASDAQ:PETQ) CEO Compensation Is Not Excessive At All
Jun 23These 4 Measures Indicate That PetIQ (NASDAQ:PETQ) Is Using Debt Extensively
May 26PetIQ, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 07PetIQ, Inc.'s (NASDAQ:PETQ) About To Shift From Loss To Profit
Apr 01Have Insiders Sold PetIQ, Inc. (NASDAQ:PETQ) Shares Recently?
Mar 11Can You Imagine How PetIQ's (NASDAQ:PETQ) Shareholders Feel About The 55% Share Price Increase?
Feb 22PetIQ, Inc. (NASDAQ:PETQ) Insiders Have Been Selling
Jan 25Is PetIQ (NASDAQ:PETQ) A Risky Investment?
Dec 30Can PetIQ (NASDAQ:PETQ) Continue To Grow Its Returns On Capital?
Dec 09Shareholder Returns
| PETQ | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -7.4% | 4.2% | -3.7% |
| 1Y | 36.1% | 2.5% | 20.2% |
Return vs Industry: PETQ exceeded the US Healthcare industry which returned 0.8% over the past year.
Return vs Market: PETQ exceeded the US Market which returned 20.5% over the past year.
Price Volatility
| PETQ volatility | |
|---|---|
| PETQ Average Weekly Movement | 5.8% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PETQ has not had significant price volatility in the past 3 months.
Volatility Over Time: PETQ's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 1,527 | Cord Christensen | petiq.com |
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.
PetIQ, Inc. Fundamentals Summary
| PETQ fundamental statistics | |
|---|---|
| Market cap | US$471.76m |
| Earnings (TTM) | US$2.13m |
| Revenue (TTM) | US$1.10b |
219.6x
P/E Ratio0.4x
P/S RatioIs PETQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PETQ income statement (TTM) | |
|---|---|
| Revenue | US$1.10b |
| Cost of Revenue | US$849.22m |
| Gross Profit | US$252.74m |
| Other Expenses | US$250.61m |
| Earnings | US$2.13m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.073 |
| Gross Margin | 22.94% |
| Net Profit Margin | 0.19% |
| Debt/Equity Ratio | 199.7% |
How did PETQ perform over the long term?
See historical performance and comparison